Detalhe da pesquisa
1.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood
; 140(4): 349-358, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316325
2.
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning.
Eur J Haematol
; 112(3): 350-359, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823328
3.
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.
Br J Haematol
; 203(2): 264-281, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539479
4.
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma.
Ann Hematol
; 102(7): 1773-1787, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171597
5.
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
Br J Haematol
; 198(3): 482-491, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362552
6.
Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation.
J Clin Immunol
; 41(6): 1250-1265, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876323
7.
Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry.
Cytotherapy
; 23(6): 483-487, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33678598
8.
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis.
Ann Hematol
; 100(9): 2339-2350, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796897
9.
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT.
Ann Hematol
; 100(8): 2095-2103, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755792
10.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31868632
11.
TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.
Pediatr Blood Cancer
; 67(6): e28302, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285995
12.
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life.
Haematologica
; 104(2): 370-379, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237266
13.
Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced age.
Future Oncol
; 15(11): 1197-1205, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30730219
14.
Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
Biol Blood Marrow Transplant
; 24(11): 2277-2284, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29964193
15.
Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis.
Ann Hematol
; 102(5): 1269-1270, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36930259
16.
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab.
Ann Hematol
; 102(1): 245-247, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394581
17.
Correction to: REMIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (polaBR), CART therapies, and lenalidomide/rituximab (R2) based on realworld data in patients with relapsed/refractory diffuse large Bcell lymphoma.
Ann Hematol
; 102(9): 2643-2644, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432417
18.
Favourable outcomes of double-hit/double-expressor lymphoma and high-grade B-cell lymphoma, not otherwise specified after early dose-intensive treatment and up-front autologous stem cell transplantation: a single-centre retrospective experience.
Br J Haematol
; 198(4): 776-779, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35620830
19.
Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation.
Br J Haematol
; 178(6): 927-935, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643323
20.
Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
N Engl J Med
; 380(17): 1676-1677, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969507